Indole-type derivatives as inhibitors of p38 kinase

Details Indole-type derivatives as inhibitors of p38 kinase Indole-type derivatives as inhibitors of p38 kinase

2007-12-04

2007-12-04

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S218000, C540S575000, C540S576000, C540S602000, C540S603000

Reexamination Certificate

active

10156996

ABSTRACT:
The invention is directed to methods to inhibit p38-α kinase using compounds containing an aromatic system coupled through a 7-membered heterocycle to an indole-type system.

REFERENCES:
patent: 3316260 (1967-04-01), Shen et al.
patent: 4088765 (1978-05-01), Winn et al.
patent: 4243806 (1981-01-01), Raeymaekers et al.
patent: 4454130 (1984-06-01), Tominaga et al.
patent: 4600715 (1986-07-01), Huth et al.
patent: 4737501 (1988-04-01), Tominago et al.
patent: 4886809 (1989-12-01), Tamada et al.
patent: 4937246 (1990-06-01), Sugihara et al.
patent: 5409941 (1995-04-01), Nowakowski
patent: 5462934 (1995-10-01), Goto et al.
patent: 5696122 (1997-12-01), Gaster et al.
patent: 5698553 (1997-12-01), Prucher et al.
patent: 5714498 (1998-02-01), Kulagowski et al.
patent: 5726177 (1998-03-01), Italazy et al.
patent: 5795907 (1998-08-01), Kalindjian
patent: 5817871 (1998-10-01), Dingerdissen et al.
patent: 6130235 (2000-10-01), Mavunkel et al.
patent: 6340685 (2002-01-01), Mavunkel et al.
patent: 6410540 (2002-06-01), Goehring et al.
patent: 6525042 (2003-02-01), Kobayashi et al.
patent: 6541477 (2003-04-01), Goehring et al.
patent: 6589954 (2003-07-01), Mavunkel et al.
patent: 2003/0092717 (2003-05-01), Dugar et al.
patent: 0 318 235 (1989-05-01), None
patent: 318 235 (1989-05-01), None
patent: 0 431 945 (1991-06-01), None
patent: 0 709 384 (1996-05-01), None
patent: 0 831 090 (1998-03-01), None
patent: 61-291566 (1986-11-01), None
patent: 2-184673 (1990-07-01), None
patent: 3-161-470 (1991-07-01), None
patent: 9-124631 (1997-09-01), None
patent: WO96/40143 (1996-12-01), None
patent: WO97/26252 (1997-07-01), None
patent: WO98/06715 (1998-02-01), None
patent: WO98/07425 (1998-02-01), None
patent: WO98/28292 (1998-07-01), None
patent: WO99/00357 (1999-01-01), None
patent: WO99/61426 (1999-12-01), None
patent: WO 00/12074 (2000-03-01), None
patent: WO 00/59904 (2000-03-01), None
patent: WO-01/07435 (2001-02-01), None
patent: WO 02/42292 (2002-05-01), None
patent: WO-02/44168 (2002-06-01), None
patent: WO 02/070491 (2002-09-01), None
Wilbrahan et al. “Organic and biological chemistry” Souther III Univ. p. 387 (1984).
Burger “A guide to the chemical basis of drug design” Wiley interscience, p. 15 (1983).
Cecil “Textbook of medicine” Sanders, p. 1395-1398 (1983).
CRC handbook of chemistry and physics 83rdedition (2002).
Trilateral project “comparative study on reach trhough claims” Nov. 2001 p. 1.
Floyd et al. “Nitrone inhibition of age-associated oxidative damage” CA 133:305179 (2000).
Adams et al. “Imidazole Compounds . . . ” CA 128:201066 (1998).
De Clerck et al. (1981).Throm. Res23:1-12.
Dukic et al. (1997).Arch. Pharm330:25-28.
Eyers, P.A. et al. “Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution”,Chem and Biol(1995) 5:321-328.
Fischer, “Physical chemical properties and local anesthetic results of an ether substitute of procaine” CA 67:10051 (1996).
Gassman, P. G., “A General Method for the Synthesis of Indoles,” J. Am. Chem. Soc., (1974) 96(17): 5495-5508.
International Search Report dated Jul. 29, 1999.
Jiang, Y. et al., “Characterization of the structure and function of a new mitogen-activated protein kinase (p38β)”J Biol Chem(1996) 271:17920-17926.
Kumar, S. et al. “Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles”,Biochem Biophys Res Comm(1997) 235:533-538.
Li, Z. et al. “The primary structure of p38γ: a new member of p38 group of MAP kinases”,Biochem Biophys Res Comm(1996) 228:334-340.
Mittendorf et al. “Preparation of Bis-Benzimidazoles . . . ” CA 132:265195 (2000).
Murai, Y., et al., “Synthesis of 4-, 5-, 6- and 7-Substituted N-Tosylindoles from Substituted Anilines,”Heterocycles, (1992) 34(5):1017-1029.
Muro et al. “Dihydrobenzofuran Derivatives” CA 88:169949 (1978).
Nakai et al. (1994). CA 121:222012.
Nakai et al. (1994). CA 121:221997.
Oelschlaeger et al. (1988). CA 109:73387.
Ogawa et al. “Studies on Positive Inotropic . . . ” CA 110:57613 (1988).
Otsuka Pharm. (1983). CA 100:51465.
Otsuka Pharm. (1983). CA 100:34414.
Otsuka Pharm. (1984). CA 100:68187.
Patani et al. “Bioisosterism: A Rational Approach in Drug Design” Chem. Rev. 96:3147-3176 (1996).
Societe Des Usine Chemiques “Anticancerous 2-Substituted . . . ” CA 77:34584 (1968).
Stein, B. et al. “p38-2, a novel mitogen-activated protein kinase with distinct properties”,J Biol Chem(1997) 272:19509-19517.
Tamada et al. “Preparation of Benzoheterocycle . . . ” CA 111:153834 (1989).
Von Strandtmann. (1971). CA 80:82713.
Wang, X.S., et al., “Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase”,J Biol Chem(1997) 272:23668-23674.
Wang, Y. et al. “Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family”,J Biol Chem(1998) 273:2161-2168.
Bennett (Ed.), Concise Chemical and Technical Dictionary, Chemical Publishing Co., Inc., New York (1974) pp. 536-537.
Grant (Ed.), Hackh's Chemical Dictionary, McGraw-Hill Book Company (1983) pp. 320-321.
Dinarello, Chest (2000) 118(2):503-508.
Hashimoto et al., Clinical and Experimental Allergy (1999-2000) 30:48-55.
Nick et al., J. Clin. Invest. (1997) 99:975-986.
Schmit et al., CA (1994) 122:53913.
Schneider et al., Chemical Abstracts (1996) 127:79417.
Berczi, CA 140 75526 (2003).
Cook, CA 132 347492 (2000).
CRC Handbook (2002) 9-26-9-43.
Daun, CA 139 117268 (2002).
Dominguez, CA 131 67650 (1999).
Heiman, CA 142 296578 (2005).
Kakihana, CA 135 313624 (2001).
Lin, CA 138 220242 (2003).
Wyngaarden Cecil Textbook of Medicine (1983) 1397-1398.

Affiliated with

Also associated with

Rating

Indole-type derivatives as inhibitors of p38 kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole-type derivatives as inhibitors of p38 kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole-type derivatives as inhibitors of p38 kinase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3837430